On November 3, 2021, Congress introduced a working draft of the Build Back Better ...
As specialty pharmaceutical products are becoming increasingly complex due to more technology-driven drug development, ...
Patient support programs (PSPs), patient assistant programs (PAPs), copay coupons, or whatever name you ...
If a life sciences company wants to start their relationship with a payer off ...
PM360 asked experts in dealing with payers to tell us the optimal strategies for ...
Rare diseases represent a major societal issue with significant costs. An estimated 400 million ...
A lot of big, unwieldy trends are impacting today’s $4 trillion healthcare landscape as ...
Treatment advances for Alzheimer’s disease took a quantum leap last year. As of early ...
At CBI’s ninth annual Coupon & Copay Forum in October, industry experts gathered both ...
In the evolving field of oncology drug development, clinical and financial insights can be ...
Over the last several years, significant investments in digital health and technology solutions have ...
For years, the rare disease community has looked forward to a time when patients ...
Most European countries have experienced more than one wave of COVID-19 infections. Lockdown and ...